COMPASS Pathways CMPS
NASDAQ CMPS
$12.14 -0.30 (-2.41%)
As of: Oct 1, 2026 · 9:39 AM EDT

COMPASS Pathways (CMPS) Liabilities and Shareholders Equity (2019 - 2026)

Updated

COMPASS Pathways (CMPS) recorded Liabilities and Shareholders Equity of $504.56 million in Q2 2026, up 71.9% from $293.54 million a year earlier but down 5.1% from the prior quarter.

Analysis

COMPASS Pathways (CMPS) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

At the end of FY2025, COMPASS Pathways reported Liabilities and Shareholders Equity of $210.35 million, down 1.6% from FY2024.

  • Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of 0.7% (FY2020 to FY2025).
  • Across earlier years, Liabilities and Shareholders Equity came in at $213.67 million in FY2024 (-22.6%), $275.99 million in FY2023 (+39.9%), $197.29 million in FY2022 (-34.4%) and $300.9 million in FY2021 (+47.9%).
  • Quarterly Liabilities and Shareholders Equity has ranged from $173.31 million in Q1 2023 to $531.74 million in Q1 2026 over the past five years.
  • On a year-over-year basis, Liabilities and Shareholders Equity rose in five of the last eight quarters, with growth averaging 13.6%.
  • Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 78.3% in Q1 2024, against a decline of 36.3% in Q1 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $531.74 million (Q1 2026), $210.35 million (Q4 2025) and $255.61 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 COMPASS Pathways 1.69 Bn 1.69 Bn - 504.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 504.56 Mn
Mar 31, 2026 531.74 Mn
Dec 31, 2025 210.35 Mn
Sep 30, 2025 255.61 Mn
Jun 30, 2025 293.54 Mn
Mar 31, 2025 319.14 Mn
Dec 31, 2024 213.67 Mn
Sep 30, 2024 247.34 Mn
Jun 30, 2024 278.53 Mn
Mar 31, 2024 308.99 Mn
Dec 31, 2023 275.99 Mn
Sep 30, 2023 299.03 Mn
Jun 30, 2023 209.83 Mn
Mar 31, 2023 173.31 Mn
Dec 31, 2022 197.29 Mn
Sep 30, 2022 224.52 Mn
Jun 30, 2022 238.64 Mn
Mar 31, 2022 272.10 Mn
Dec 31, 2021 300.90 Mn
Sep 30, 2021 314.74 Mn
API Access

COMPASS Pathways Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CMPS&period=max&api_key=YOUR_API_KEY